期刊文献+

急性冠状动脉综合征与白细胞介素-18临床关系的研究 被引量:2

THE CLINICAL RELATIONSHIP BETWEEN ACUTE CORONARY SYNDROME AND INTERLEUKIN-18
下载PDF
导出
摘要 目的:研究干扰素-γ诱导因子白细胞介素-18(IL-18)血清浓度与冠心病临床不稳定情况,即急性冠状动脉综合征(ACS)之间的关系。方法:采用酶联免疫吸附法(ELISA)检测68例冠心病患者和31例正常健康者血清IL-18、IL-10的水平,并比较上述指标水平与急性冠状动脉综合征之间的关系。结果:血清IL-18水平在急性心肌梗死(AM I)组和不稳定性心绞痛(UAP)组显著高于稳定性心绞痛(SAP)组和对照组,在AM I组和UAP组患者之间血清IL-18水平无显著性差异,血清IL-10水平在AM I组和UAP组则明显低于SAP组和对照组;SAP组血清IL-10水平也低于对照组。结论:急性冠状动脉综合征患者血清IL-18水平明显升高且与抗炎因子IL-10呈负相关关系;IL-18可能是促进斑块不稳定而发生溃疡、破裂、急性血栓形成从而导致急性冠状动脉综合征的重要因素。 Objective :To investigate the relationship between serum density of interleukin- 18( IL- 18) induced by interferon -γ( IFN -γand clinical unstability of Coronary Heart Disease (CHD) or called Acute Coronary Syndrome (ACS). Methods:To examine the serum density of IL - 18 and IL - 10 of 68 cases CHD patients and 31 cases health people using enzyme linked immunosorbent assay(ELISA), and to compare the relation between their serum density and ACS. Results :The serum density of IL- 18 in Acute Myocardial Infarction (AMI) group and Unstability Angina Pectoris(UAP) group were obviously higher than serum density in Stability Angina Pectoris(SAP) group and control group. There was not difference in serum density of IL - 18 between AMI group and UAP group. Serum density of IL -10 in SAP group was lower than control group. Concluslon:The serum density of IL -18 in ACS patients is obviously higher than health people and shows negative correlation with anti - inflammatory factor IL - 10. IL - 18 maybe an important reason to promote instability of coronary plaque and ulceration, rapture, acute thrombosis, then to result in ACS.
出处 《牡丹江医学院学报》 2006年第4期12-16,共5页 Journal of Mudanjiang Medical University
关键词 白细胞介素-18 白细胞介素-10 急性冠状动脉综合征 Interleukin - 18 (IL-18 ) Interleukin - 10 (IL- 10) Acute Coronary Syndrome (ACS)
  • 相关文献

参考文献24

  • 1Biasucci LM,Santamana M,Liuizzo G..Inflammation,atherosclerosis and acute coronary syndromes[J].MinerVa Cardioangiol,2002,50(5):475 -486.
  • 2Raykk,CampNJ,Bennett CE,et al.Genetic variation at the interleukin-1 locus is a determinant of changes in soluble endothelial factors in patients with acute coronary syndromes[J].Clin Sci (Lond),2002,103(3):303 -310.
  • 3VohnoutB,Di Castelnuovo A,Trotta R,et al.Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease[J].Haematologica.2003,88 (1):54-60.
  • 4Stephens JW,Humphries SE.The molecular genetics of cardiovascular disease:clinical implications[J].J Intern Med,2003,253(2):120 -127.
  • 5RallidisLS,ZolindakiMG,Manioudaki HS,et al.Prognostic value of C-reactive protein,fibrinogen,interleukin-6,and macrophage colony stimulating factor in severe unstable angina[J].Clin Cardiol,2002,25(11):505 -510.
  • 6Natio Y,TsujinoT,Fujioka Y,et al.Increased circulating interleukin-18 in patients with Congestive heart failure[J].Heart,2002,88(3):296-297.
  • 7Raeburn CD,Dinarello CA,Zimmernan MA,et al.Neutra lization of IL-18 attenuates Lipopolysaccharide-induced myocardial dysfunction[J].Am J Physiol Heart Circ Physiol,2002,283 (2):H650-657.
  • 8Yamaoka-Tojo M,Tojo T,Inomata T,et al.Circulating levels of interleukin-18 reflect etiologies of heart failure:Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure[J].J Card Fail,2002,8(1):21 -27.
  • 9Kanda T,Tanaka T,Sekiguchi K,et al.Effect of interleukin-18 on viral myocarditis:enhancement of interferon-gamma and natureal killer cell activity[J].J Mol Cell Cardial,2000,32(12):2163 -2171.
  • 10Mallat Z,Corbaz A,Scoazec A,et al.Expression of interleukin-18in human atherosclerotic plaques and relation to plaque instability[J].Circulation,2001,104(14):1598-1603.

二级参考文献57

  • 1金冬雁 黎盂枫译.分子克隆(第2版)[M].北京:科学出版社,1995..
  • 2[1]Ross R.Atherosclerosis:an inflammatory disease[J].N Engl J Med,1999,340:115.
  • 3[2]Okamura H,Tsutsi H,Komatsu T,et al.Cloning of a new cytokine that induces IFN-γ production by T cell[J].Nature,1995,378:88.
  • 4[3]Bazan JF,Timans JC,Kastelein RA.A newly defined interleukin-1[J]?Nature,1996,375:591.
  • 5[4]Okamura H,Tsutsui H,Kashiwamura S,et al.Interleukin-18:a novel cytokine that augments both innate and acquired immunity[J].Adv Immunol,1998,70:281.
  • 6[5]Dinarello CA.Interleukin-18,a proinflammatory cytokine[J].Eur Cytokine Netw,2000,11:483.
  • 7[6]Stewart CW,Punnaivanam R,Alan D.Interleukin-18 enhances atherosclerosis in apolipoprotein E-/- mice through release of interferon-γ[J].Circ Res,2002,90:e34.
  • 8[7]Norbert G,Galina K,Sukhova,Peter L,et al.Expression of Interleukin(IL)-18 and functional IL-18 receptor on human vascular endothelial cells,smooth muscle cells,and macrophages:implications for atherogenesis[J].Circulation,2000,18:11.
  • 9[8]Zial M,Anne C,Alexandra S,et al.Expression of Interleukin-18 in human atherosclerotic plaques and relation to plaque instability[J].Circulation,2001,104:1598.
  • 10[9]Zial M,Anne C,Alexandra S,et al.Interleukin-18/Interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability[J].Circ Res,2001,89:e41.

共引文献53

同被引文献28

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部